Plasma proteomics: A noninvasive window on pathology and pediatric cardiac surgery

Melinda E. Lull, Willard M. Freeman, John L. Myers, Frank Midgley, Stephen J. Kimatian, Akif Ündar, Kent E. Vrana

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

A challenge of pediatric research is the limited ability to obtain tissue samples from small patients. To confront this problem, blood biomarkers can be used as surrogate markers of disease processes and aid in patient monitoring and disease detection. Furthermore, proteomic analysis of plasma samples is one approach for large-scale discovery of disease biomarkers. This study examined the use of plasma for disease process biomarkers in pediatric patients undergoing cardiopulmonary bypass (CPB) surgery. Proteomic studies of plasma are limited by the presence of a few high abundance proteins that mask the presence of lower abundance proteins of interest. Plasma immunoaffinity depletion (removing 6 of the highest abundance proteins of little pathological importance) increases sensitivity of detection for proteins such as those related to inflammation, remodeling, and damage. Using two-dimensional in-gel fluorescence electrophoresis, changes in the expression levels of proteins that occur as a result of CPB can be identified. In the present study, plasma depletion removed 83% of the plasma protein mass, allowing approximately 1400 spots to be observed by two-dimensional in-gel fluorescence electrophoresis. Of the detected spots, 79 (5.7%) were altered by CPB. These data illuminate the strength of plasma proteomics in identification of candidate biomarkers of CPB-associated disease processes.

Original languageEnglish (US)
Pages (from-to)562-566
Number of pages5
JournalASAIO Journal
Volume52
Issue number5
DOIs
StatePublished - Sep 1 2006

Fingerprint

Pediatrics
Pathology
Proteomics
Surgery
Thoracic Surgery
Biomarkers
Cardiopulmonary Bypass
Plasmas
Proteins
Electrophoresis
Fluorescence
Gels
Patient monitoring
Physiologic Monitoring
Masks
Blood Proteins
Blood
Tissue
Inflammation
Research

ASJC Scopus subject areas

  • Bioengineering
  • Biophysics
  • Medicine(all)
  • Biomaterials
  • Biomedical Engineering

Cite this

Lull, M. E., Freeman, W. M., Myers, J. L., Midgley, F., Kimatian, S. J., Ündar, A., & Vrana, K. E. (2006). Plasma proteomics: A noninvasive window on pathology and pediatric cardiac surgery. ASAIO Journal, 52(5), 562-566. https://doi.org/10.1097/01.mat.0000237694.53808.78

Plasma proteomics : A noninvasive window on pathology and pediatric cardiac surgery. / Lull, Melinda E.; Freeman, Willard M.; Myers, John L.; Midgley, Frank; Kimatian, Stephen J.; Ündar, Akif; Vrana, Kent E.

In: ASAIO Journal, Vol. 52, No. 5, 01.09.2006, p. 562-566.

Research output: Contribution to journalArticle

Lull, ME, Freeman, WM, Myers, JL, Midgley, F, Kimatian, SJ, Ündar, A & Vrana, KE 2006, 'Plasma proteomics: A noninvasive window on pathology and pediatric cardiac surgery', ASAIO Journal, vol. 52, no. 5, pp. 562-566. https://doi.org/10.1097/01.mat.0000237694.53808.78
Lull, Melinda E. ; Freeman, Willard M. ; Myers, John L. ; Midgley, Frank ; Kimatian, Stephen J. ; Ündar, Akif ; Vrana, Kent E. / Plasma proteomics : A noninvasive window on pathology and pediatric cardiac surgery. In: ASAIO Journal. 2006 ; Vol. 52, No. 5. pp. 562-566.
@article{123e91ee36344d7599e6def05f60287f,
title = "Plasma proteomics: A noninvasive window on pathology and pediatric cardiac surgery",
abstract = "A challenge of pediatric research is the limited ability to obtain tissue samples from small patients. To confront this problem, blood biomarkers can be used as surrogate markers of disease processes and aid in patient monitoring and disease detection. Furthermore, proteomic analysis of plasma samples is one approach for large-scale discovery of disease biomarkers. This study examined the use of plasma for disease process biomarkers in pediatric patients undergoing cardiopulmonary bypass (CPB) surgery. Proteomic studies of plasma are limited by the presence of a few high abundance proteins that mask the presence of lower abundance proteins of interest. Plasma immunoaffinity depletion (removing 6 of the highest abundance proteins of little pathological importance) increases sensitivity of detection for proteins such as those related to inflammation, remodeling, and damage. Using two-dimensional in-gel fluorescence electrophoresis, changes in the expression levels of proteins that occur as a result of CPB can be identified. In the present study, plasma depletion removed 83{\%} of the plasma protein mass, allowing approximately 1400 spots to be observed by two-dimensional in-gel fluorescence electrophoresis. Of the detected spots, 79 (5.7{\%}) were altered by CPB. These data illuminate the strength of plasma proteomics in identification of candidate biomarkers of CPB-associated disease processes.",
author = "Lull, {Melinda E.} and Freeman, {Willard M.} and Myers, {John L.} and Frank Midgley and Kimatian, {Stephen J.} and Akif {\"U}ndar and Vrana, {Kent E.}",
year = "2006",
month = "9",
day = "1",
doi = "10.1097/01.mat.0000237694.53808.78",
language = "English (US)",
volume = "52",
pages = "562--566",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Plasma proteomics

T2 - A noninvasive window on pathology and pediatric cardiac surgery

AU - Lull, Melinda E.

AU - Freeman, Willard M.

AU - Myers, John L.

AU - Midgley, Frank

AU - Kimatian, Stephen J.

AU - Ündar, Akif

AU - Vrana, Kent E.

PY - 2006/9/1

Y1 - 2006/9/1

N2 - A challenge of pediatric research is the limited ability to obtain tissue samples from small patients. To confront this problem, blood biomarkers can be used as surrogate markers of disease processes and aid in patient monitoring and disease detection. Furthermore, proteomic analysis of plasma samples is one approach for large-scale discovery of disease biomarkers. This study examined the use of plasma for disease process biomarkers in pediatric patients undergoing cardiopulmonary bypass (CPB) surgery. Proteomic studies of plasma are limited by the presence of a few high abundance proteins that mask the presence of lower abundance proteins of interest. Plasma immunoaffinity depletion (removing 6 of the highest abundance proteins of little pathological importance) increases sensitivity of detection for proteins such as those related to inflammation, remodeling, and damage. Using two-dimensional in-gel fluorescence electrophoresis, changes in the expression levels of proteins that occur as a result of CPB can be identified. In the present study, plasma depletion removed 83% of the plasma protein mass, allowing approximately 1400 spots to be observed by two-dimensional in-gel fluorescence electrophoresis. Of the detected spots, 79 (5.7%) were altered by CPB. These data illuminate the strength of plasma proteomics in identification of candidate biomarkers of CPB-associated disease processes.

AB - A challenge of pediatric research is the limited ability to obtain tissue samples from small patients. To confront this problem, blood biomarkers can be used as surrogate markers of disease processes and aid in patient monitoring and disease detection. Furthermore, proteomic analysis of plasma samples is one approach for large-scale discovery of disease biomarkers. This study examined the use of plasma for disease process biomarkers in pediatric patients undergoing cardiopulmonary bypass (CPB) surgery. Proteomic studies of plasma are limited by the presence of a few high abundance proteins that mask the presence of lower abundance proteins of interest. Plasma immunoaffinity depletion (removing 6 of the highest abundance proteins of little pathological importance) increases sensitivity of detection for proteins such as those related to inflammation, remodeling, and damage. Using two-dimensional in-gel fluorescence electrophoresis, changes in the expression levels of proteins that occur as a result of CPB can be identified. In the present study, plasma depletion removed 83% of the plasma protein mass, allowing approximately 1400 spots to be observed by two-dimensional in-gel fluorescence electrophoresis. Of the detected spots, 79 (5.7%) were altered by CPB. These data illuminate the strength of plasma proteomics in identification of candidate biomarkers of CPB-associated disease processes.

UR - http://www.scopus.com/inward/record.url?scp=33748698273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748698273&partnerID=8YFLogxK

U2 - 10.1097/01.mat.0000237694.53808.78

DO - 10.1097/01.mat.0000237694.53808.78

M3 - Article

C2 - 16966860

AN - SCOPUS:33748698273

VL - 52

SP - 562

EP - 566

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 5

ER -